SISTERSVILLE GENERAL HOSPITAL — History
CCN 511304 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
+69.8%
Revenue CAGR (3yr)
2.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $6M | $12M | $17M | +38.5% | +69.8% |
| Operating Expenses | $9M | $13M | $17M | +24.8% | +33.0% |
| Operating Margin | -59.1% | -8.3% | 2.4% | +128.5% | +0.0% |
| Net Income | $-3M | $-1M | $0M | +139.4% | +0.0% |
| Licensed Beds | 12 | 4 | 6 | +50.0% | -29.3% |
| Total Patient Days | 171 | 546 | 1,099 | +101.3% | +153.5% |
| Medicare Day % | 70% | 36% | 41% | +16.5% | -23.2% |
| Medicaid Day % | nan% | 0% | 9% | +2458.6% | +nan% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +188.2% ($6M → $17M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+69.8%
This Hospital
+7.6%
State Avg
Latest Margin
2.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $22M | 33.1% |
| FY2024 (proj) | $28M | 63.8% |
| FY2025 (proj) | $34M | 94.5% |